Results 71 to 80 of about 10,150 (104)

[ECoTES index of occupational safety and health (OSH) system performance: results of a pilot study in six Ibero-American countriesÍndice ECoTES de desempenho do sistema de segurança e saúde no trabalho: resultados de um estudo-piloto em seis países ibero-americanos]. [PDF]

Rev Panam Salud Publica
Benavides FG, Cornelio C, Carmenate L, Barraza D, Gimeno Ruiz de Porras D, Vives A, Rojas M, Palomo L, López-Ruiz M, Amable M, Merino-Salazar P, Silva-Peñaherrera M.   +11 more
europepmc   +1 more source

Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors. [PDF]

J Immunother Cancer
Mathiot L, Combarel D, Cagnat J, Delahousse J, Ouali K, Marabelle A, Loriot Y, Ponce S, Champiat S, Broutin S, Danlos FX.   +10 more
europepmc   +1 more source

Clinical isolates of <i>Providencia rettgeri</i> and <i>Providencia Stuartii</i> evades neutrophil-mediated killing by subverting neutrophil-extracellular traps. [PDF]

Front Immunol
Castro JE, Birnberg-Weiss F, Toloza MJ, Bertinat YA, Fuentes F, Peyloubet A, Faccone D, Gómez SA, Landoni VI, Fernández GC.   +9 more
europepmc   +1 more source

Dolutegravir-based Antiretroviral Therapy in People With HIV With Solid Organ Transplantation: A Single-arm Pilot Clinical Trial (DTG-SOT). [PDF]

Open Forum Infect Dis
Miro JM, Malano-Barletta D, Berrocal L, Manzardo C, Castelli A, Brunet M, Roman O, Ambrosioni J, Cofán F, Gonzalez A, Ruiz P, Crespo G, Forner A, Ángeles Castel M, Laguno M, Tuset M, de Lazzari E, Rimola A, Moreno A, SOT in HIV-infected patients Working Group Investigators .   +19 more
europepmc   +1 more source

Prevalence of Chlamydia trachomatis in an asymptomatic female population attending cervical cytology services of three healthcare centers in Medellín, Colombia [PDF]

Biomedica, 2020
Orozco-Hoyos N, Baena A, Montoya-Ruiz C, Sánchez GI, Restrepo E.   +4 more
europepmc   +1 more source

Risk factors for candidemia: a prospective matched case-control study. [PDF]

Crit Care, 2020
Poissy J, Damonti L, Bignon A, Khanna N, Von Kietzell M, Boggian K, Neofytos D, Vuotto F, Coiteux V, Artru F, Zimmerli S, Pagani JL, Calandra T, Sendid B, Poulain D, van Delden C, Lamoth F, Marchetti O, Bochud PY, FUNGINOS, Allfun French Study Groups.   +20 more
europepmc   +1 more source

COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer. [PDF]

Br J Cancer
Segal NH, Tie J, Kopetz S, Ducreux M, Chen E, Dienstmann R, Hollebecque A, Reilley MJ, Elez E, Cosaert J, Cain J, Soo-Hoo Y, Hewson N, Cooper ZA, Kumar R, Tabernero J.   +15 more
europepmc   +1 more source

Lymphoplasmacytic lymphoma associated with diffuse large B-cell lymphoma: Progression or divergent evolution? [PDF]

PLoS One, 2020
Boiza-Sánchez M, Manso R, Balagué O, Chamizo C, Askari E, Salgado RN, Blas-López C, Aguirregoicoa-García E, Menárguez J, Santonja C, Adrados M, Limeres-González MÁ, Piris MÁ, Rodríguez-Pinilla SM.   +13 more
europepmc   +1 more source

Pembrolizumab plus either epacadostat or placebo for cisplatin-ineligible urothelial carcinoma: results from the ECHO-307/KEYNOTE-672 study. [PDF]

BMC Cancer
Necchi A, Van der Heijden MS, Trukhin D, Peer A, Gurney H, Alekseev BY, Parnis FX, Leibowitz R, De Santis M, Grivas P, Clark J, Munteanu M, Kataria R, Jia C, Balar AV, de Wit R.   +15 more
europepmc   +1 more source